Neurocrine Biosciences Inc (NBIX) SEC Filings — 2024
15 SEC filings for Neurocrine Biosciences Inc (NBIX) in 2024.
Filings
- Neurocrine Biosciences Files 8-K — 8-K · Dec 20, 2024
- Neurocrine Biosciences Files 8-K — 8-K · Nov 1, 2024
- Neurocrine Biosciences Files Q3 2024 10-Q Report — 10-Q · Oct 30, 2024
- Neurocrine Biosciences Inc SC 13G Filing — SC 13G · Oct 17, 2024
- Neurocrine Biosciences Announces Executive and Director Changes — 8-K · Oct 11, 2024
- Neurocrine Biosciences Files 8-K — 8-K · Aug 28, 2024
- Neurocrine Biosciences Q2 2024 Update — 10-Q · Aug 1, 2024
- Neurocrine Biosciences Elects New Directors, Amends Bylaws — 8-K · May 28, 2024
- Neurocrine Biosciences Adds Dr. P. Brandon Davis to Board — 8-K · May 23, 2024
- Neurocrine Biosciences Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 1, 2024
- Neurocrine Biosciences Inc. Files Definitive Proxy Statement — DEF 14A · Apr 10, 2024
- Vanguard Trims Neurocrine Bio Stake to 10.7% — SC 13G/A · Feb 13, 2024
- Neurocrine Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 9, 2024
- Neurocrine Biosciences Files 8-K on Financial Results — 8-K · Feb 7, 2024
- BlackRock Amends Neurocrine Biosciences Stake (SC 13G/A) — SC 13G/A · Jan 23, 2024